OBI Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	907.54	1,732	899.28	4,741	2,512	3,338
Short-Term Investments	673.7	1,399	1,883	30.71	140	-
Trading Asset Securities	-	0.09	0.23	0.75	1.77	383.53
Cash & Short-Term Investments	1,581	3,131	2,782	4,773	2,654	3,722
Cash Growth	12.50%	12.53%	-41.70%	79.83%	-28.69%	-23.44%
Accounts Receivable	4.41	4.2	6.48	2.04	3.47	1.45
Other Receivables	257.1	19.01	30.82	26.24	19.8	17.57
Receivables	261.51	23.21	37.29	28.27	23.27	19.02
Inventory	26.07	27.73	25.93	21.97	9.56	7.36
Prepaid Expenses	28.25	258.01	221.43	211.26	167.35	146.6
Other Current Assets	-	-	100.34	-	-	-
Total Current Assets	1,897	3,440	3,167	5,034	2,854	3,895
Property, Plant & Equipment	1,033	1,165	1,249	1,176	1,149	918.22
Long-Term Investments	793.61	959.85	1,070	8.73	9.11	8.04
Goodwill	-	-	-	61.15	61.15	61.15
Other Intangible Assets	51.32	62.84	73.18	321.29	337.14	392.73
Other Long-Term Assets	53.8	26.13	51.64	32.9	76.21	64.9
Total Assets	3,829	5,654	5,611	6,634	4,487	5,340
Accounts Payable	1.87	3.44	0.77	1.14	0.53	0.16
Accrued Expenses	41	251.9	65.76	112.49	177.82	67.69
Short-Term Debt	41.86	0.41	4.31	15.71	-	9.47
Current Portion of Long-Term Debt	71.58	34.09	7	7	7	9
Current Portion of Leases	53.74	55.12	49.86	40.35	52.07	37.08
Current Income Taxes Payable	1.75	10.39	1.58	0.56	0.34	1.11
Current Unearned Revenue	6.66	7.78	6.29	3.16	-	-
Other Current Liabilities	153.03	49.24	30.28	40.73	89.47	123.98
Total Current Liabilities	371.47	412.37	165.84	221.14	327.22	248.49
Long-Term Debt	47.54	48.22	60.06	67.07	28	35
Long-Term Leases	323.59	366.79	425.89	163.03	205.96	155.41
Long-Term Deferred Tax Liabilities	-	-	-	46.33	54.76	63.2
Other Long-Term Liabilities	6.11	6.01	5.89	0	-	-
Total Liabilities	748.7	833.39	657.67	497.57	615.95	502.09
Common Stock	2,632	2,632	2,294	2,294	1,993	1,993
Additional Paid-In Capital	9,113	9,101	7,128	6,933	3,702	3,685
Retained Earnings	-9,512	-7,879	-5,569	-4,523	-2,909	-1,378
Treasury Stock	-26.53	-26.53	-26.53	-45.99	-45.99	-53.83
Comprehensive Income & Other	-19.72	-12.09	-19.87	-26.32	-24.53	-16.79
Total Common Equity	2,186	3,815	3,807	4,632	2,716	4,229
Minority Interest	894.11	1,006	1,147	1,504	1,155	608.74
Shareholders' Equity	3,081	4,820	4,953	6,136	3,871	4,838
Total Liabilities & Equity	3,829	5,654	5,611	6,634	4,487	5,340
Total Debt	538.29	504.63	547.11	293.15	293.03	245.95
Net Cash (Debt)	1,043	2,626	2,235	4,479	2,361	3,476
Net Cash Growth	18.63%	17.49%	-50.10%	89.73%	-32.08%	-24.19%
Net Cash Per Share	8.06	22.48	19.52	40.33	23.73	35.01
Filing Date Shares Outstanding	131.48	131.48	114.62	114.55	99.47	99.45
Total Common Shares Outstanding	131.48	131.48	114.62	114.55	99.47	99.45
Working Capital	1,526	3,027	3,001	4,813	2,527	3,646
Book Value Per Share	16.63	29.01	33.21	40.44	27.30	42.53
Tangible Book Value	2,135	3,752	3,734	4,250	2,318	3,775
Tangible Book Value Per Share	16.24	28.53	32.57	37.10	23.30	37.96
Land	-	-	-	87.51	87.51	87.51
Buildings	344.49	344.49	343.2	370.02	329.28	328.66
Machinery	1,109	1,080	1,022	1,054	671.26	695.35
Construction In Progress	5.96	10.07	66.46	35.74	368.45	117.37
Leasehold Improvements	276.8	276.85	181.24	184.06	65.85	73.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.